Dover (DOV)
(Delayed Data from NYSE)
$176.33 USD
-4.04 (-2.24%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $176.29 -0.04 (-0.02%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$176.33 USD
-4.04 (-2.24%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $176.29 -0.04 (-0.02%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Zacks News
Dover (DOV) Earnings Beat Estimates in Q3, Lowers FY22 View
by Zacks Equity Research
Dover's (DOV) Q3 results gains on strong demand and robust backlog levels as well as improving price-cost dynamics.
Dover Corporation (DOV) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Dover Corporation (DOV) delivered earnings and revenue surprises of 2.73% and 0.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Idex (IEX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover (DOV) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Dover's (DOV) Q3 performance is likely to have benefited from the solid order trends across segments, driven by strong demand and margin-improvement actions.
Dover Corporation (DOV) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Dover Corporation (DOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DOV vs. NDSN: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOV vs. NDSN: Which Stock Is the Better Value Option?
DOV or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DOV vs. IEX: Which Stock Is the Better Value Option?
Dover's (DOV) Arm Inks Deal to Offer Complete Fuel Solutions
by Zacks Equity Research
Dover (DOV) business unit DFS's latest partnership with Bottomline will provide combined fuel management solution to customers that can save retailers' costs by 5-10% through automated operations.
Is Dover (DOV) a Suitable Stock for Value Investors?
by Zacks Equity Research
Is Dover (DOV) a great pick from the value investor's perspective right now? Read on to know more.
Here's Why Investors Should Retain Dover (DOV) Stock For Now
by Zacks Equity Research
Dover (DOV) is benefiting from solid order trends, strong demand across end markets and cost-control actions despite supply chain challenges and escalating costs.
Dover (DOV) Earnings Beat Estimates in Q2, Sales Up Y/Y
by Zacks Equity Research
Dover's (DOV) Q2 top line benefits from strong demand and robust backlog levels.
Dover Corporation (DOV) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Dover Corporation (DOV) delivered earnings and revenue surprises of 2.88% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Idex (IEX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover (DOV) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Dover's (DOV) Q2 performance is likely to have benefited from the solid order trends across segments, stemming from strong demand and margin-improvement actions.
Dover Corporation (DOV) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Dover Corporation (DOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover (DOV) Rides on Strong Demand & Buyouts Amid High Costs
by Zacks Equity Research
Dover (DOV) is benefiting from strong demand across end markets, strategic acquisitions and cost-control actions despite supply chain challenges and escalating costs.
Dover (DOV) Closes Malema Buyout, Boosts Biopharma Portfolio
by Zacks Equity Research
Dover (DOV) is working toward building its biopharma platform through new product developments and opportunistic acquisitions, with the Malema buyout being the latest.
Lindsay (LNN) to Report Q3 Results: What's in the Cards?
by Zacks Equity Research
Lindsay's (LNN) Q3 performance is likely to reflect benefits from increased demand for irrigation equipment and transportation safety products.
Apogee (APOG) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Apogee's (APOG) Q1 performance will likely benefit from strong order levels, pricing actions and productivity improvement efforts.
Xylem (XYL) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Investors Should Retain Dover (DOV) Stock Now
by Zacks Equity Research
Dover (DOV) is benefiting from solid order trends, strong demand across end markets and cost-control actions despite supply chain challenges and escalating costs.
Dover (DOV) to Acquire Malema, Expand Biopharma Offerings
by Zacks Equity Research
Dover (DOV) to acquire manufacturer of flow-measurement devices for biopharma and semiconductor production applications.
Dover (DOV) Earnings & Sales Beat Estimates in Q1, Up Y/Y
by Zacks Equity Research
Dover's (DOV) Q1 top-line performance benefits from strong demand and robust order and backlogs levels.
Dover Corporation (DOV) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Dover Corporation (DOV) delivered earnings and revenue surprises of 3.26% and 1.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stocks to Watch for Earnings on Apr 21: DOV, PNR & SON
by Namrata Chatterjee
The industrial sector will likely witness a 3.9% growth in Q1 earnings. A sneak peek at how Dover Corporation (DOV), Pentair plc (PNR) and Sonoco Products (SON) will likely fare in Q1.